Until recently the scientific community accepted aging as something natural and inevitable, but now it is seen as a master disease that is treatable, can be slowed, even reversed.
This transformative perspective has ignited a new era of research and innovation, leading to remarkable breakthroughs in combating the effects of aging.

the solution

We now possess a much better understanding of the pathophysiology of age-related eye conditions, and it is evident that the root cause is genetic. Equipped with new gene therapy techniques, we have the potential to not only significantly slow down the progression of ocular diseases but also facilitate their reversal, including the regeneration of the optic nerve.

our first target : glaucoma

Glaucoma is the leading cause of irreversible blindness worldwide.
We are currently developing a groundbreaking approach that utilizes gene therapy to regenerate the damaged optic nerve while at the same time providing neuroprotection.
This discovery represents a potential cure for glaucoma that has the ability to restore patients' lost vision, something previously considered impossible.

The delivery of our gene therapy to the optic nerve is accomplished through a minimally invasive outpatient procedure known as intravitreal injection. This approach eliminates the need for invasive surgery, making it a convenient and accessible option for patients.

Frequently Asked Questions (FAQ) About Glaucoma

What are the major predisposing factors that cause glaucoma?

There are several predisposing factors, but the two primary ones are elevated intraocular pressure (IOP) and aging.

How do I know if I have glaucoma?

Detecting glaucoma, even in its advanced stages, is quite challenging. Chronic glaucoma typically doesn't manifest symptoms like pain or heaviness in the eyes, earning it the nickname 'the silent thief of sight.' Accurate diagnosis relies on a thorough assessment by a specialized ophthalmologist, involving measurements of intraocular pressure (IOP), optic nerve examination, and other tests such as visual fields examination.

So what happens if I am diagnosed with glaucoma?
There If you have already experienced visual field loss, traditional glaucoma treatments cannot restore those lost areas. You will likely be prescribed daily eye drops aimed at lowering intraocular pressure (IOP) to slow down the progression of the disease. Unfortunately, this may be a lifelong regimen. However, one potential avenue for regaining lost vision is through nerve regenerative gene therapy offered by GENORASIS.
Is lowering IOP a valid way to cure glaucoma?
Unfortunately, no. Lowering the IOP might slow down the progression of glaucoma, meaning it can reduce the rate at which the nerve fibers of the optic nerve deteriorate, but it doesn't stimulate the regeneration of these nerve fibers nor does it restore lost vision.

Can we use gene therapy to reduce the IOP and eliminate the need for eye drops?

Possibly, but in this case, gene therapy presents certain disadvantages when compared to traditional methods of IOP reduction such as eye drops or valve implants. If the target IOP isn't achieved while using eye drops, the doctor can make adjustments to the dosage, prescribe an alternative drug, or add one or more drugs as needed. This flexibility doesn't seem feasible with gene therapy, potentially requiring additional interventions. However, it's important to note that while this approach can slow down the progression of glaucoma, it does not offer nerve regeneration or restoration of lost vision.

So what hope is there?
A beacon of hope lies in a groundbreaking gene therapy developed by GENORASIS. This innovative approach holds the promise of regenerating the lost axons of ganglion cells damaged by glaucoma, neuritis or optic nerve injury. Moreover, there is potential for enhancing neuroprotection, bolstering the resilience of newly grown and existing axons, and potentially reducing the need for eye drops in the future.

the crystalline lens

Targeting the crystalline lens with gene therapy to avoid alterations in its structure, morphology and function that leads initially to the diminished ability to focus in different distances (presbyopia) and later to opacification that severely impairs visual acuity and the perception of images and colors (cataract).


  • Targeting the retina and especially the macula to prevent Age-Related Macular Degeneration and Diabetic Retinopathy, but also to improve color perception and visual acuity.
  • Targeting the diseases and conditions that cause the deterioration and loss of nerve fibers in the optic nerve, including glaucoma, optic neuritis, injuries, and the inevitable loss from aging.